20
Participants
Start Date
December 1, 2018
Primary Completion Date
December 1, 2022
Study Completion Date
December 1, 2022
Gallium-68 DOTATATE
Gallium-68 DOTATATE is a radioactive tracer, a type of imaging drug that is labeled with a radioactive tag and injected into the body, which is approved by the U.S. Food and Drug Administration (FDA) to diagnose certain tumors.
University of Pennsylvania, Philadelphia
Collaborators (1)
Advanced Accelerator Applications
INDUSTRY
University of Pennsylvania
OTHER